Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishna Radhakrishnan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Chemical Communications (Cambridge, England)|January 24, 2012
Biologically triggered exploding protein based microcapsules for drug deliveryKrishna Radhakrishnan, Ashok M Raichur
Chemical Communications (Cambridge, England)|May 9, 2013
Dual enzyme responsive microcapsules simulating an "OR" logic gate for biologically triggered drug delivery applicationsKrishna Radhakrishnan, Jasaswini Tripathy, Ashok M Raichur
Artificial Intelligence in Medicine|January 26, 2020
Signal identification system for developing rehabilitative device using deep learning algorithmsWenping Tang, Aiqun Wang, S Ramkumar, et al.
International Journal of Nanomedicine|February 6, 2020
Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating Animal StudiesSyed Abdullah Alkaff, Krishna Radhakrishnan, Anu Maashaa Nedumaran, et al.
International Journal of Nanomedicine|January 25, 2013
Intracellular delivery of doxorubicin encapsulated in novel pH-responsive chitosan/heparin nanocapsulesMidhun B Thomas, Krishna Radhakrishnan, Divya P Gnanadhas, et al.
Pharmaceutics|July 25, 2019
Hollow Microcapsules as Periocular Drug Depot for Sustained Release of Anti-VEGF ProteinKrishna Radhakrishnan, Anita Vincent, Rini Rachel Joseph, et al.
Drug Discovery Today|November 8, 2016
Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteinsKrishna Radhakrishnan, Nirmal Sonali, Miguel Moreno, et al.
Expert Opinion on Drug Delivery|May 13, 2016
Drug, delivery and devices for diabetic retinopathy (3Ds in DR)Jayabalan Nirmal, Krishna Radhakrishnan, Miguel Moreno, et al.
Expert Opinion on Drug Delivery|June 24, 2017
Modulating release of ranibizumab and aflibercept from thiolated chitosan-based hydrogels for potential treatment of ocular neovascularizationMiguel Moreno, Poh Yih Pow, Tan Su Teng Tabitha, et al.
ACS Applied Materials & Interfaces|February 5, 2026
Toward Rapid Actinium-225 Purification via Membrane Adsorbers with Covalently Tethered Diglycolamide LigandsShruti Krishna Radhakrishnan, Megan M Sibley, Bernadette L Schneider, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|January 24, 2012
Biologically triggered exploding protein based microcapsules for drug deliveryKrishna Radhakrishnan, Ashok M Raichur
Chemical Communications (Cambridge, England)|May 9, 2013
Dual enzyme responsive microcapsules simulating an "OR" logic gate for biologically triggered drug delivery applicationsKrishna Radhakrishnan, Jasaswini Tripathy, Ashok M Raichur
Artificial Intelligence in Medicine|January 26, 2020
Signal identification system for developing rehabilitative device using deep learning algorithmsWenping Tang, Aiqun Wang, S Ramkumar, et al.
International Journal of Nanomedicine|February 6, 2020
Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating Animal StudiesSyed Abdullah Alkaff, Krishna Radhakrishnan, Anu Maashaa Nedumaran, et al.
International Journal of Nanomedicine|January 25, 2013
Intracellular delivery of doxorubicin encapsulated in novel pH-responsive chitosan/heparin nanocapsulesMidhun B Thomas, Krishna Radhakrishnan, Divya P Gnanadhas, et al.
Pharmaceutics|July 25, 2019
Hollow Microcapsules as Periocular Drug Depot for Sustained Release of Anti-VEGF ProteinKrishna Radhakrishnan, Anita Vincent, Rini Rachel Joseph, et al.
Drug Discovery Today|November 8, 2016
Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteinsKrishna Radhakrishnan, Nirmal Sonali, Miguel Moreno, et al.
Expert Opinion on Drug Delivery|May 13, 2016
Drug, delivery and devices for diabetic retinopathy (3Ds in DR)Jayabalan Nirmal, Krishna Radhakrishnan, Miguel Moreno, et al.
Expert Opinion on Drug Delivery|June 24, 2017
Modulating release of ranibizumab and aflibercept from thiolated chitosan-based hydrogels for potential treatment of ocular neovascularizationMiguel Moreno, Poh Yih Pow, Tan Su Teng Tabitha, et al.
ACS Applied Materials & Interfaces|February 5, 2026
Toward Rapid Actinium-225 Purification via Membrane Adsorbers with Covalently Tethered Diglycolamide LigandsShruti Krishna Radhakrishnan, Megan M Sibley, Bernadette L Schneider, et al.
Pageof 1